Literature DB >> 9769715

Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies.

R C Ribeiro1, J W Apriletti, R L Wagner, B L West, W Feng, R Huber, P J Kushner, S Nilsson, T Scanlan, R J Fletterick, F Schaufele, J D Baxter.   

Abstract

This review summarizes the studies conducted in our laboratory on the mechanisms of thyroid hormone action over the past two decades. We have attempted to place our studies on thyroid hormone receptors (TRs) in perspective with the work conducted by other investigators that established their nuclear localization, DNA-binding properties, DNA response elements, and the role of other proteins involved in TR-mediated regulation of gene transcription. Recently, our crystallographic studies of the TR ligand binding domain (LBD) revealed that the ligand has a structural role in the folding of the receptor's hydrophobic core. The analysis of the structure led to biochemical and genetic studies that have defined the surfaces on the TR LBD required for dimerization and binding of coactivator proteins. Placement of the mutations found in patients with the syndrome of generalized resistance to thyroid hormone on the TR LBD revealed that they were restricted to amino acids in the vicinity of the binding pocket for thyroid hormone. The insights gained from the elucidation of the TR LBD structure will provide the basis for the design of compounds with selective agonistic or antagonistic activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769715

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  19 in total

1.  The orphan nuclear receptor Ear-2 is a negative coregulator for thyroid hormone nuclear receptor function.

Authors:  X G Zhu; K S Park; M Kaneshige; M K Bhat; Q Zhu; C N Mariash; P McPhie; S Y Cheng
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Structure of a thyroid hormone receptor DNA-binding domain homodimer bound to an inverted palindrome DNA response element.

Authors:  Yi Chen; Matthew A Young
Journal:  Mol Endocrinol       Date:  2010-07-07

3.  Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2005-01-13

4.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

5.  Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.

Authors:  I H Chan; M L Privalsky
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

6.  Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.

Authors:  M Jeyakumar; Paul Webb; John D Baxter; Thomas S Scanlan; John A Katzenellenbogen
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

7.  A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)beta2.

Authors:  Sangho Lee; Briana M Young; Wei Wan; Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2011-05-26

8.  Research resource: identification of novel coregulators specific for thyroid hormone receptor-β2.

Authors:  Johnnie B Hahm; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2013-04-04

9.  The ability of thyroid hormone receptors to sense t4 as an agonist depends on receptor isoform and on cellular cofactors.

Authors:  Amy Schroeder; Robyn Jimenez; Briana Young; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2014-03-27

10.  IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3.

Authors:  Janaina S de Souza; Cassiano Carromeu; Laila B Torres; Bruno H S Araujo; Fernanda R Cugola; Rui M B Maciel; Alysson R Muotri; Gisele Giannocco
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.